Patient Pathfinder: Clinical Trials
Clinical Trials for Lung Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 989 active Lung Cancer trials
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
Study Type: Interventional Phase 1
Olaparib in Patients With HRD Malignant Mesothelioma
Study Type: Interventional Phase 2
Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial
Study Type: Interventional Phase 1
Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
Study Type: Interventional Phase 1
Recurrence Monitoring in NSCLC Using Circulating Tumor DNA
Study Type: Observational
Improving Utilization of Lung Cancer Screening in Underserved PA Populations
Study Type: Interventional
Longitudinal Metabolomic and Epigenetic Profiling of Bodyfluids From Patients With Lung and Brain Cancer Receiving Radiation Therapy
Study Type: Observational
Lorlatinib Combinations in Lung Cancer
Study Type: Interventional Phase 1
There are 989 active Lung Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now